-
Most Popular
![Biotech Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/biotech-150x150.png)
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Biochemical/biotech research scientist team working with microscope](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715-150x150.png)
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
![Nurse holding a tablet with icons representing different aspects of healthcare and healthcare data representing CANO stock. Healthcare Tech Stocks. Healthcare Stocks to Buy](https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600-150x150.jpg)
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
Why Is Atreca (BCEL) Stock Up 85% Today?
Atreca stock is heading higher on Thursday as investors react to news of Baker Bros. Advisors LP increasing its stake in the company.
Why Is Xeris Biopharma (XERS) Stock Up 12% Today?
Xeris Biopharma stock is rising higher on Wednesday as investors in XERS shares react to a new exclusive worldwide license agreement.
Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock
Investors in Recursion Pharmaceuticals and RXRX stock have a couple of key catalysts to point to as reasons to buy big right now.
NexImmune (NEXI) Stock Rockets 80% Ahead of Potential Liquidation
NEXI stock is rising higher ahead of a potential liquidation and dissolution of NexImmune. Here's what you need to know.
10 Things to Know as Gotham City Slams Grifols (GRFS) Stock in New Short Report
GRFS stock is plunging lower following accusations of undisclosed related party transactions and financial irregularities.
Why Is Sarepta Therapeutics (SRPT) Stock Up Today?
Sarepta Therapeutics stock is rising higher on Tuesday as SRPT investors react to positive comments from company CEO Douglas Ingram.
Why Is Cyclacel Pharmaceuticals (CYCC) Stock Down 9% Today?
Cyclacel Pharmaceuticals stock is slipping on Tuesday after shares of CYCC rallied on Monday alongside it regaining Nasdaq compliance.
Why Is Grifols (GRFS) Stock Down 38% Today?
Grifols stock is falling hard as investors sell GRFS shares after the company was hit with a short report from Gotham City Research.
Why Is Elicio Therapeutics (ELTX) Stock Up 11% Today?
Elicio Therapeutics stock is up with heavy trading of ELTX shares are posting positive preliminary results from a Phase 1 clinical trial.
Why Is Ambrx Biopharma (AMAM) Stock Up 100% Today?
With Johnson & Johnson buying out Ambrx Biopharma, the win-win deal boosted AMAM stock while better positioning J&J’s oncology unit.
Why Is LumiraDx (LMDX) Stock Down 13% Today?
LumiraDx stock is falling hard on Monday as investors in LMDX prepare for the company's shares to be delisted on Tuesday!
Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today?
Cellectar Biosciences stock is up on Monday as investors celebrate positive study results with heavy trading of CLRB stock this morning.
Why Is Harpoon Therapeutics (HARP) Stock Up 111% Today?
Harpoon Therapeutics stock is rocketing higher on Monday as HARP investors react to Merck acquiring the company for $23 per share.
$10K to $100K: Small-Cap Marvels With Massive Upside
Unlocking the potential of small-cap companies often reveals sky-bound stocks. The three listed stocks in the article offer substantial growth opportunities.